Murj Competitive Intelligence & Landscape
murj.com ·
Overview
Murj Overview
Murj Weekly Intel Updates
Receive weekly intel updates about Murj straight to your inbox.
Competitors
Murj Competitors
GOQii is another significant player, known for its wearable health tech and wellness platform, which competes indirectly by targeting health monitoring and patient engagement, emphasizing consumer health rather than clinical device management growjo.Lumere, on the other hand, specializes in healthcare data analytics and clinical decision support, providing tools that help hospitals optimize device usage and procurement, making it a strong indirect competitor by enhancing clinical decision-making processes Tracxn.
In the broader landscape, Klue and other competitive intelligence platforms like Asana are not direct competitors but provide insights into competitive positioning and market trends, which can be valuable for Murj’s strategic planning The Weekly Byte. Murj’s key differentiator remains its specialized focus on implantable cardiac device management, automation of device reporting, and patient impact tracking, which sets it apart from more generalized health tech solutions or analytics providers. Pricing and market share data indicate Murj’s strong growth trajectory, evidenced by its repeated inclusion on the Inc. 5000 list, and its revenue of approximately $16.9M positions it competitively within the niche market of cardiac health management Murj, growjo.
Sources
Murj - 2026 Company Profile, Team, Funding & Competitors - Tracxn
tracxn.com
Murj earns spot on Inc. 5000 fastest-growing US companies list for ...
murj.com
Murj: Revenue, Competitors, Alternatives - Growjo
growjo.com
What is Competitive Landscape of Asana Company? – MatrixBCG.com
matrixbcg.com
Compare Miru | Miru vs Harvest, FreshBooks, Toggl, Clockify, Monday, TimeCamp
miru.so
Competitor Analysis: A Framework for Turning Rivals Into Opportunities | Aether Agency
aether-agency.co.uk
Klue Alternative for Competitor Tracking (2026) | The Weekly Byte
theweeklybyte.com
Product & Pricing
Murj Product and Pricing Intelligence
Sources
Murj – Different from the start - Murj
murj.com
Murj - Oncely
oncely.com
Murj License Agreement Terms & Conditions
murj.com
Introducing the Murj Dedicated Heart Failure Platform
murj.com
Product Overview - Murj
murj.com
Pricing Intelligence for Competitor Price Monitoring
webdataguru.com
Murj CIED Management Platform - Murj
murj.com
Murj | Company Profile - Revenue, Headcount, Tech Stack, Contacts
bitscale.ai
Ad Campaigns
Murj Ad Campaigns
Murj is currently running 12 ads across Google — 12 on Google. Explore Murj's live ad creative, messaging, and the platforms they advertise on in the ad library — updated automatically by ForesightIQ.
See of Murj's ads
Browse the live creative across Google, Meta & LinkedIn in the ad library
Hiring & Layoffs
Murj Hiring and Layoffs
In terms of hiring trends, Murj appears to be expanding its team, with reports from early 2026 indicating an employee count of around 44, reflecting ongoing growth and a focus on scaling its operations (Tracxn). The company is likely hiring for roles that support its platform development, customer support, and sales functions, aligning with its strategy to solidify its market position and enhance its product offerings (Murj Careers).
While there are no recent reports of layoffs, the company's sustained growth and funding status suggest a stable employment environment with a focus on innovation and market expansion. Murj's hiring patterns signal a strategic emphasis on technological advancement, customer acquisition, and operational scaling, aiming to maintain its leadership in remote cardiac device management and healthcare interoperability (Murj LinkedIn). Overall, Murj's recent activities and hiring trends reflect a company focused on growth, innovation, and strengthening its competitive edge in the healthcare tech space.
Sources
Leadership
Murj Management and Leadership Team
Todd Butka serves as the CEO and Founder, leading the company's vision in cardiac care technology (The Org). Other notable executives include Reed Gaither as COO, Patrick Beaulieu as CTO, and Chris Irving as CXO, all of whom contribute to the company's growth and innovation (Growjo).
Recent leadership updates indicate that the core leadership structure remains stable, with no publicly reported major changes at the C-suite level as of April 2026. The company’s executive team also features roles such as Director of Customer Success, VP of Product, VP of Sales, and Director of Finance, supporting various operational and strategic functions (The Org).
Murj's board members and other notable hires at the executive level are not explicitly detailed in the available sources. However, the company’s leadership team, including its founders and senior management, continues to focus on advancing cardiac device management solutions, supported by a growing team of over 120 employees (Growjo). This leadership stability and expansion reflect Murj’s ongoing commitment to innovation in digital health and cardiac care management.
Financials
Murj Financial Performance, Fundraising, M&A
Regarding funding, Murj has raised a total of $14.1 million, with its latest funding round being a Series B, which further supports its financial health and growth trajectory (bitscale), seedtable). Notably, the company secured $8.5 million in May 2018 during a Series B round led by Longitude Capital, with participation from True Ventures and other investors (mobihealthnews).
In terms of M&A activity, there is no publicly available information indicating recent acquisitions or mergers involving Murj as of April 2026. The company continues to focus on expanding its cloud-based platform for managing implantable cardiac devices, which has contributed to its revenue growth and market presence (tracxn). Overall, Murj remains a financially healthy and actively funded player in the digital health and medical device management industry.
Sources
How Murj hit $15.4M revenue with a 100 person team in 2024.
getlatka.com
Murj Company Information - Funding, Investors, and More
staging.seedtable.com
Implantable cardiac device data collector Murj lands $8.5M | MobiHealthNews
mobihealthnews.com
Murj | Company Profile - Revenue, Headcount, Tech Stack, Contacts
bitscale.ai
Murj - 2026 Company Profile, Team, Funding & Competitors - Tracxn
tracxn.com
Murj Revenue and Competitors
growjo.com
Partnerships
Murj Partnerships, Clients and Vendors
Murj's platform integrates with multiple vendor systems, consolidating data from various manufacturers to streamline workflows and improve clinical care. This integration capability is central to its solutions, which include the Murj CIED Management Platform, Heart Failure Monitoring, and Pulmonary Artery Pressure Monitoring, emphasizing its ecosystem relationships with device manufacturers and healthcare providers (Result 2).
Furthermore, Murj partners with healthcare institutions like the University of South Florida, which has adopted its platform to manage over 4,000 patients, showcasing its enterprise client base and its role in scaling remote cardiac care operations. Murj also emphasizes ongoing support and strategic collaboration, partnering with clinics to ensure confidence and efficiency from implementation through daily operations (Results 3, Result 7). This ecosystem of collaborations and integrations underscores Murj’s position as a key player in remote cardiac device management and healthcare technology innovation.
Sources
Introducing Murj Certified Service Partners
murj.com
Murj – Different from the start - Murj
murj.com
Strategic Support - Murj
murj.com
Case study: Optimizing systems integration with CIED clinic workflow increased revenue and staff efficiency - Murj
murj.com
CIED remote monitoring FAQ: Picking the right partner - Murj
murj.com
Blog - Murj
murj.com
Strategic Support - Murj
murj.com
Murj – Different from the start - Murj
murj.com
Events
Murj Event Participations
Murj’s presence at HIMSS 2026 highlights its focus on enterprise interoperability and cardiac device management, emphasizing its commitment to advancing healthcare technology and fostering industry collaborations (Murj). The company’s ongoing sponsorship and attendance at such events demonstrate its dedication to staying at the forefront of healthcare innovation and community engagement, making it a key player in the remote cardiac monitoring and interoperability space (Murj News).
Frequently Asked Questions
What does Murj's record 2025 growth — surpassing 1,100 clinics and 900,000 patients — signal about its competitive moat in cardiac device management?
Murj's scale signals a defensible network moat: with 1,100-plus clinics and 900,000 patients on platform by end of 2025, switching costs for healthcare providers become substantial as workflows, integrations, and historical data are embedded in the Murj ecosystem. For a company with roughly 44–120 employees (sources vary), that patient volume per headcount is exceptionally high, suggesting strong platform leverage rather than a services-heavy model. Competitors entering this space face the dual challenge of matching both the vendor integrations Murj has built and the installed base it has accumulated.
Murj's Series B was raised in May 2018 — what does the absence of a subsequent funding round suggest about its financial strategy and burn rate?
The gap between Murj's 2018 Series B ($8.5M led by Longitude Capital, with True Ventures participating) and its current operations — at approximately $15.4M in 2024 revenue — strongly implies the company has reached or is near cash-flow breakeven on a relatively lean capital base of $14.1M total raised. This is a signal of capital efficiency unusual in digital health, and it likely reflects a subscription revenue model with low marginal cost per additional clinic. The absence of further dilutive rounds may also indicate the founders are managing toward a clean exit or that growth has been self-funded through recurring revenue expansion.
What does Murj's HIMSS 2026 presence — specifically its dual placement in Booth 419 and the Interoperability Marketplace — reveal about its near-term product positioning?
Securing presence in both the main exhibit hall and the Interoperability Marketplace at HIMSS 2026 signals that Murj is actively repositioning from a point solution for cardiac device data into a broader interoperability player. The Interoperability Marketplace placement in particular is a deliberate signal to health system IT buyers and EHR vendors that Murj wants to be part of the enterprise data integration conversation, not just the cardiology department workflow. This is consistent with its platform consolidating data from multiple device manufacturers — a capability that becomes more valuable as health systems push for unified patient records.
With an employee count that sources place anywhere from 44 to 120+, what does the ambiguity itself tell a corp-dev analyst about Murj's organizational maturity?
The wide variance in reported headcount — Tracxn cites roughly 44 while Growjo references 120-plus — suggests Murj relies heavily on its Certified Service Partners for delivery capacity rather than direct headcount, effectively outsourcing a portion of its operational workforce. For a corp-dev analyst, this means an acquirer should assess the true economic headcount including partner dependencies, as a direct acquisition would not automatically internalize those clinical operations. It also suggests the company may be deliberately staying lean at the corporate level to maintain attractive unit economics ahead of a potential exit.
What does Murj's Certified Service Partners Program — including Equis Consulting Group, Prep MD, Cardiac RMS, and Heartwatch Solutions — signal about its go-to-market model?
The Certified Service Partners Program signals that Murj has built an indirect channel to scale clinic penetration without proportionally growing its own sales and implementation headcount. Partners collectively managing over 100,000 cardiac device patients nationwide effectively serve as a distributed sales and service force, lowering Murj's customer acquisition cost while expanding geographic reach. For competitive analysts, this means displacing Murj requires not just winning the software evaluation but also dislodging established partner relationships that have their own economic incentives to maintain Murj deployments.
How should Murj's Inc. 5000 inclusion and ~$16.9M revenue estimate be interpreted relative to its total funding of only $14.1M?
Murj generating approximately $15–17M in annual revenue against a total funding base of $14.1M is a strong signal of revenue exceeding cumulative external capital — an unusual and favorable ratio in venture-backed health IT. Repeated inclusion on the Inc. 5000 list corroborates consistent multi-year growth rather than a single spike. For a strategic acquirer, this trajectory suggests a company that has validated its model without significant dilution, potentially making valuation negotiations more straightforward than for a heavily funded peer with unclear paths to profitability.
What does the University of South Florida's adoption of Murj to manage over 4,000 patients signal about Murj's enterprise readiness?
USF's adoption as an enterprise reference client indicates Murj has cleared the compliance, security, and integration requirements necessary to operate within an academic medical center — a higher bar than a community cardiology clinic. A 4,000-patient deployment at a single institution also demonstrates the platform's ability to scale within a single health system, which is a key proof point for larger IDN and hospital system sales cycles. This reference is likely a significant asset in competitive evaluations where enterprise prospects require evidence of comparable-scale deployments.
Todd Butka has been CEO since founding — what does founder-led stability at this revenue scale signal about Murj's likely strategic priorities?
A founder-led company at $15–17M in revenue with stable C-suite (COO Reed Gaither, CTO Patrick Beaulieu, CXO Chris Irving) and no reported leadership turnover suggests Murj is not in a distressed or transitional state, and that the founding vision remains intact. Founder CEOs at this stage typically prioritize strategic control, meaning an outright acquisition may require meaningful premium or earnout structures to align incentives. However, the maturing executive team — with dedicated VP of Product, VP of Sales, and Director of Finance roles — signals the company is professionalizing its infrastructure in ways that could be preparing it for either a growth round or an exit process.
What does Murj's multi-product expansion into Heart Failure Monitoring and Pulmonary Artery Pressure Monitoring signal about its platform ambition versus its original CIED focus?
Murj's expansion beyond implantable cardiac device management into Heart Failure and Pulmonary Artery Pressure Monitoring signals a deliberate strategy to become the comprehensive remote cardiac monitoring platform rather than a narrow CIED data aggregator. Each new monitoring category adds recurring revenue streams from existing clinic relationships and raises the cost of switching by deepening workflow integration. For competitors and acquirers alike, this breadth means Murj is targeting a larger share of the cardiac care budget per clinic rather than simply adding net-new clinic logos.
What does Murj's subscription-based pricing model with Basic, Pro, and Enterprise tiers imply about its revenue concentration risk?
A tiered subscription model across Basic, Pro, and Enterprise plans suggests Murj has structured its revenue to capture both small independent cardiology practices and larger health systems, reducing dependence on any single customer segment. However, with approximately 1,100 clinics on platform and $15–17M in revenue, average revenue per clinic is relatively modest — roughly $14,000–$15,000 annually — which implies the enterprise tier has meaningful upside if health systems are underpenetrated or on lower-tier plans. Revenue concentration risk depends heavily on what share of ARR comes from the handful of large institutional clients like USF versus the long tail of smaller clinics.
Given that Murj's most commonly cited competitors — Paradigm, GOQii, Lumere — are not pure-play cardiac device management platforms, what does that competitive gap signal about market structure?
The absence of a direct, well-funded pure-play competitor in the cardiac device management space is itself a significant market signal: the segment may be too narrow to attract large-scale independent venture investment but large enough to be a valuable tuck-in for a major health IT player, cardiac device manufacturer, or RPM platform. Murj's most relevant competitive threats likely come from adjacent players — EHR vendors extending into remote monitoring, or device OEMs like Medtronic and Abbott building proprietary monitoring platforms — rather than the generalist digital health companies typically cited. ForesightIQ tracks device manufacturer platform moves as the more material competitive risk to Murj's independent positioning.
What does Murj's active blogging, webinar cadence, and HIMSS participation suggest about where it is in its sales cycle maturity?
A company at Murj's revenue scale maintaining active content marketing, webinar programming, and tier-one conference presence is investing in top-of-funnel demand generation — a pattern more consistent with an organization still in active market expansion than one in harvest mode. This cadence suggests Murj believes there is substantial whitespace remaining in its addressable clinic market and is investing to capture it, rather than simply renewing and expanding within its existing base. For a strategic buyer, this signals that a significant portion of Murj's eventual market share is still unrealized, which could support a premium valuation argument based on pipeline rather than current revenue alone.
Powered by ForesightIQ · Competitive intelligence from digital exhaust